← Leaderboards
Qin Liu
Massachusetts Eye And Ear Infirmary
$2,373,472
Attributed
$2,373,472
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $637.6K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,373,472 · 1
By mechanism
R01$2,373,472 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts Eye And Ear Infirmary
Same institution · by research overlap
- Kinga Bujakowska$3,333,485
- Jason Comander$2,099,500
- Mitchell Lee Day$1,373,625
- Joe C Adams$4,627,355
- Konstantina M Stankovic$5,863,319
Others in their field
Other Rising Stars on “Europe”
- Maria Yazdanbakhsh · Leiden University Medical Center$2,600,040
- Trevor Smith · Wistar Institute$2,597,245
- Youssef Oulhote · University Of Massachusetts Amherst$2,536,947
- Irene N Papanicolas · Brown University$2,393,910
- Jonathan Robert Sukovich · University Of Michigan At Ann Arbor$1,999,023
- Leah H Schinasi · Drexel University$1,955,953
Research focus
EuropeDependovirusAdeno-Associated Viral VectorEmerging AdultAffectAnimalsAntisense OligonucleotidesAlternative SplicingBaseAlternative TherapiesAmino AcidsBilateral Hearing LossBiological ProcessBirthBlindnessCell LineCellsClinical ResearchCodeComplementCrispr/Cas TechnologyBase EditingBase EditorEvent
Grant awards (4)
CRISPR/Cas9-based gene editing approaches for the treatment of USH2A-associated diseases$505,799
R01 · FY2025 · EY · contact PI
CRISPR/Cas9-based gene editing approaches for the treatment of USH2A-associated diseases$595,058
R01 · FY2024 · EY · contact PI
CRISPR/Cas9-based gene editing approaches for the treatment of USH2A-associated diseases$637,558
R01 · FY2023 · EY · contact PI
CRISPR/Cas9-based gene editing approaches for the treatment of USH2A-associated diseases$635,057
R01 · FY2022 · EY · contact PI